K M Mattila
Overview
Explore the profile of K M Mattila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anttila S, Huuhka K, Huuhka M, Rontu R, Mattila K, Leinonen E, et al.
J Neural Transm (Vienna)
. 2006 Oct;
114(4):461-8.
PMID: 17066254
We studied the association between tryptophan hydroxylase 1 (TPH1) A218C and G-protein beta-3 subunit (GNB3) C825T polymorphisms and treatment response in electroconvulsive therapy (ECT). The sample consisted of 119 patients...
2.
Kampman O, Illi A, Hanninen K, Katila H, Anttila S, Rontu R, et al.
J Neural Transm (Vienna)
. 2006 Apr;
113(10):1563-8.
PMID: 16604300
The aims of the present study were to compare the allele frequencies of a common single nucleotide polymorphism located upstream of the regulator of G-protein signaling 4 (RGS4) gene (T...
3.
FREY H, Mattila K, Korolainen M, Pirttila T
Neurochem Res
. 2005 Dec;
30(12):1501-10.
PMID: 16362769
The etiopathogenesis of Alzheimer's disease (AD) is still unclear, although clinical diagnostic criteria exist and the neuropathology of AD has been studied in great detail during the last 20 years....
4.
Anttila S, Illi A, Kampman O, Mattila K, Lehtimaki T, Leinonen E
J Neural Transm (Vienna)
. 2004 Nov;
112(7):885-90.
PMID: 15526143
Several studies have connected brain-derived neurotrophic factor (BDNF) with treatment response to neuroleptics. In recent studies, the BDNF expression was reduced by typical neuroleptics. We conducted a retrospective study on...
5.
Mattila K, Rinne J, Roytta M, Laippala P, Lehtimaki T
Acta Neurol Scand
. 2002 Aug;
106(3):128-30.
PMID: 12174171
Objective: To test for an association between an estrogen receptor 1 (ESR1) gene polymorphism and Parkinson's disease with dementia (PDD) in Finnish subjects. Subjects And Methods: Forty-one clinically demented and...
6.
Mattila K, Rinne J, Lehtimaki T, Roytta M, Ahonen J, Hurme M
J Med Genet
. 2002 Jun;
39(6):400-2.
PMID: 12070246
No abstract available.
7.
Lehtimaki T, Laaksonen R, Mattila K, Janatuinen T, Vesalainen R, Nuutila P, et al.
Eur J Clin Invest
. 2002 Jun;
32(6):400-4.
PMID: 12059984
Background: Oxidised low-density lipoprotein (ox-LDL) is a determinant of impaired coronary function and oestrogens inhibit its formation probably throughout genetically-variable oestrogen receptor 1 (ESR1) in artery wall. We hypothesized that...
8.
Pollanen P, Karhunen P, Mikkelsson J, Laippala P, Perola M, Penttila A, et al.
Arterioscler Thromb Vasc Biol
. 2001 Sep;
21(9):1446-50.
PMID: 11557670
Matrix metalloproteinase 9 (MMP9) is expressed in human atherosclerotic plaques, and the protein is localized in human coronary atherosclerotic lesions. The MMP9 gene has a C-to-T promoter polymorphism at position...
9.
Mattila K, Luomala M, Lehtimaki T, Laippala P, Koivula T, Elovaara I
Neurology
. 2001 May;
56(9):1246-7.
PMID: 11342704
No abstract available.
10.
Mattila K, Rinne J, Roytta M, Laippala P, Pietila T, Kalimo H, et al.
J Med Genet
. 2000 Oct;
37(10):766-70.
PMID: 11015454
Alzheimer's disease (AD) and Parkinson's disease (PD) are genetically heterogeneous. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) genes may modify the risk of these disorders. We investigated whether common polymorphisms...